Balanced hydroxyethylstarch preparations: Are they all the same? In-vitro thrombelastometry and whole blood aggregometry

European Journal of Anaesthesiology

Volumn 26, Issue 12, 2009, Pages 1020-1025

  Boldt, Joachim ^a   Mengistu, Andinet ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Balanced hydroxyethylstarch; Gelatin; Haemodilution; Platelet function; Thrombelastometry; Whole blood aggregomery

Indexed keywords

BALANCED HETASTARCH; CALCIUM; GELATIN; HETASTARCH; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING PARAMETERS; BLOOD CLOTTING TIME; CONTROLLED STUDY; HEMODILUTION; HUMAN; IN VITRO STUDY; MALE; NORMAL HUMAN; THROMBOCYTE AGGREGATION; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; METHODOLOGY; MOLECULAR WEIGHT; THROMBOELASTOGRAPHY; TREATMENT OUTCOME;

ADULT; BLOOD COAGULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GELATIN; HETASTARCH; HUMANS; MALE; MOLECULAR WEIGHT; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; THROMBELASTOGRAPHY; TREATMENT OUTCOME; WHOLE BLOOD COAGULATION TIME;

EID: 77449120837     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e32832f5a90     Document Type: Article

References (28)

1. Jungheinrich C, Neff TA. Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet 2005; 44: 681-699.
2. deJonge E, Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med 2001; 29: 1261-1267.
3. Kozek-Langenecker SA. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 2005; 103: 654-660.
4. Strauss RG, Pennell BJ, Stump DC. A randomized, blinded trial comparing the hemostatic effects of pentastarch versus hetastarch. Transfusion 2002; 42: 27-36.
5. Haynes GH, Havidich JE, Payne KJ. Why the Food and Drug Administration changed the warning label for hetastarch. Anesthesiology2004; 101 : 560-561.
6. Treib J, Haass A, Pindur G. Coagulation disorders caused by hydroxyethyl starch. Thromb Haemost 1997; 78: 974-983.
7. Wilkes MM, Navickis RJ, Sibbald WJ. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg 2001; 72: 527-533.
8. Sanfelippo MJ, Suberviola PD, Geimer NF. Development of a von Willebrand-like syndrome after prolonged use of hydroxyethyl starch. Am J Clin Pharmacol 1987; 88: 653-655.
9. Stögermuller B, Stark J, Willschke H, et al. The effect of hydroxyethylstarch 200 kD on platelet function. Anesth Analg 2000; 91: 823-827.
10. Franz A, Bräunlich P, Gamsjager T, et al. The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg 2001; 92: 1402-1407.
11. Haisch G, Boldt J, Krebs C, et al. Influence of a new hydroxyetyhlstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients. J Cardiothorac Vasc Anesth 2001; 15: 316-321.
12. Kozek-Langenecker SA, Jungheinrich C, Sauermann W, Van der Linden P. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials. Anesth Analg 2008; 107: 382-390.
13. Lehmann G, Marx G, Förster H. Bioequivalence comparison between hydroxyethyl starch 130/0.42/6: 1 and hydroxyethyl starch 130/0.4/9: 1. Drugs R&D 2007; 8: 229-240.
14. Wilkes NJ, Woolf RL, Powanda MC, et al. Hydroxyethyl starch in balanced electrolyt solution (Hextend): pharmacokinetic and pharmacodynamic profiles in healthy volunteers. Anesth Analg 2002; 94: 538-644.
15. Gan TJ, Bennett-Guerrero E, Phillips-Bute B, et al. Hextend, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Anesth Analg1999; 88: 992-998.
16. Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use ofviscoelastic point-of-care coagulation devices. Anesth Analg 2008; 106: 1366-1375.
17. Mengistu AM, Wolf MW, Boldt J, et al. Evaluation of a new platelet function analyzer in cardiac surgery: a comparison of modified thromboelastography and whole-blood aggregometry. J Cardiothorac Vasc Anaesth 2008; 22: 40-46.
18. Handy JM, Soni N. Physiological effects of hyperchloraemia and acidosis. Br J Anaesth 2008; 101 : 141-150.
19. Roche AM, James MF, Grocott MP, Mythen MG. Coagulation effects of in vitro serial haemodilution with a balanced electrolyte hetastarch solution compared with a saline-based hetastarch solution and lactated Ringer's solution. Anaesthesia 2002; 57: 950-955.
20. Halmajä Hillman K, Bishop G, Bristow P. The crystalloid versus colloid controversy: present status. Balliere's Clin Anaesth 1997; 11: 1-13.
21. Fries D, Innerhofer P, Klingler A, et al. The effect of the combined administration of colloids and lactated Ringer's solution on the coagulation system: an in vitro study using thrombelastograph coagulation analysis (ROTEG). Anesth Analg 2002; 94: 1280-1287.
22. Von Roten I, Madjdpour C, Frascarolo P, et al. Molar subsitution and C2/C6 ratio of hydroxylethyl starch: influence on blood coagulation. Br J Anaesth 2006; 96: 455-463.
23. Deusch E, Thaler U, Kozek-Langenecker SA. The effects of high molecular weight hydroxyethyl starch solutions on platelets. Anesth Analg 2004; 99: 665-668.
24. Blaicher AM, Reiter WJ, Blaicher W, et al. The effect ofhydroxyethyl starch on platelet aggregation in vitro. Anesth Analg 1998; 86: 1318-1321.
25. Treib J, Haass A, Pindur G, et al. All medium starches are not the same: influence of the degree of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation. Transfusion 1996; 36: 450-455.
26. Gorton H, Lyons G, Manraj P. Preparation for regional anaesthesia induces changes in thrombelastography. Br J Anaesth 2000; 84: 403-404.
27. Nielsen VG, Baird MS. Extreme hemodilution in rabbits: an in vitro and in vitro thrombelastographic analysis. Anesth Analg 2000; 90: 541-545.
28. Payen JF, Baruch M, Horvilleur E, et al. Changes in specific markers of haemostasis during reduction mammoplasty. BrJAnaesth 1998; 80: 464-466.